Aaron Fox-Collis - 28 Dec 2023 Form 4 Insider Report for Fresh Tracks Therapeutics, Inc. (FRTX)

Role: VP of Finance & CAO
Signature: /s/ Griffin D. Foster, Attorney-in-Fact for Aaron Fox-Collis (power of attorney previously filed)
Issuer symbol: FRTX
Transactions as of: 28 Dec 2023
Net transactions value: -$7,280
Form type: 4
Filing time: 09 Jan 2024, 16:11:03 UTC
Previous filing: 11 Dec 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FRTX	Restricted Stock Units	Disposed to Issuer	$7,280	-8,000	-100%	$0.9100	0	28 Dec 2023	Common Stock	8,000		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Prior to December 28, 2023, each restricted stock unit ("RSU") represented a contingent right to receive one share of issuer common stock upon settlement. Effective on December 28, 2023, the issuer's board of directors terminated the Fresh Tracks Therapeutics, Inc. (the "Company") 2020 Omnibus Long-Term Incentive Plan (the "Plan") and all unvested RSUs granted under the Plan. The value of the terminated RSUs was replaced with a right to a cash payment valued by multiplying the number of RSUs by the closing price of the Company's common stock on such date (the "Cash Payment").
F2	The Cash Payment will vest in full on the first anniversary of the grant date of the RSUs.

Content

Prior to December 28, 2023, each restricted stock unit ("RSU") represented a contingent right to receive one share of issuer common stock upon settlement. Effective on December 28, 2023, the issuer's board of directors terminated the Fresh Tracks Therapeutics, Inc. (the "Company") 2020 Omnibus Long-Term Incentive Plan (the "Plan") and all unvested RSUs granted under the Plan. The value of the terminated RSUs was replaced with a right to a cash payment valued by multiplying the number of RSUs by the closing price of the Company's common stock on such date (the "Cash Payment").

The Cash Payment will vest in full on the first anniversary of the grant date of the RSUs.